FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Terpenes

  • Home
  •  | 
  • Tag Archives: "Terpenes"

Relevium Announces Strategic Investment in Leading Pediatric Cannabis Company and Obtains Exclusive License for the Canadian Market

MONTREAL, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:  “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has executed a binding letter of intent for a strategic investment into CannaKids.org for an initial 25% equity. Cannakids is a leader in the medical cannabis patient research and consumer product development for pediatric and adult applications.
Read more

Abattis Bioceuticals Provides Phase 1 Update on Research and Development for Nanoemulsification and Liposomal Platforms of Cannabinoid-Rich Hemp Oil

Abattis Bioceuticals Provides Phase 1 Update on Research and Development for Nanoemulsification and Liposomal Platforms of Cannabinoid-Rich Hemp Oil
Phase 1 of the study was a comparison of studies of transmucosal (stomach lining) vs sublingual (under the tongue) absorption of cannabinoids. The focus of this study is to confirm that sublingual absorption is indeed superior in terms of providing a higher percentage of successful cannabinoid reception into the bloodstream, providing much faster medical benefits through increasingly efficient absorption. Abattis is currently in the running to be one of the first bioceuticals companies to publish public research on sublingual and transmucosal absorption of cannabinoids.
Read more